Avacta Group Plc (AVCTF)
OTCMKTS · Delayed Price · Currency is USD
0.6420
-0.0300 (-4.46%)
At close: Aug 1, 2025
Avacta Group Market Cap
Avacta Group has a market cap or net worth of $257.84 million as of August 22, 2025. Its market cap has decreased by -14.31% in one year.
Market Cap
257.84M
Enterprise Value
273.20M
Revenue
141.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.64
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 70.11M to 257.84M, an increase of 267.77%. That is a compound annual growth rate of 7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 257.84M | 12.58% |
| Dec 31, 2024 | 229.04M | -44.84% |
| Dec 29, 2023 | 415.23M | 15.51% |
| Dec 30, 2022 | 359.48M | -16.19% |
| Dec 31, 2021 | 428.94M | 10.49% |
| Dec 31, 2020 | 388.21M | 883.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |